Friday, Sep 29, 2023
English News
  • Hyderabad
  • Telangana
  • AP News
  • India
  • World
  • Entertainment
  • Science and Tech
  • Sport
  • Business
  • Rewind
  • ...
    • NRI
    • View Point
    • cartoon
    • Columns
    • Education Today
    • Reviews
    • Property
    • Videos
    • Lifestyle
E-Paper
  • NRI
  • View Point
  • cartoon
  • Columns
  • Reviews
  • Education Today
  • Property
  • Videos
  • Lifestyle
Home | Hyderabad | Uoh Startup And Indras Research Proposes Drug For Covid 19 Treatment

UoH Startup and INDRAS research proposes drug for Covid-19 treatment

The first result offering a safe, ready-to-use and cost-effective solution for Covid-19 treatment, Ertugliflozin is an FDA approved drug for type-2 diabetes.

By Telangana Today
Published Date - 04:14 PM, Thu - 1 July 21
UoH Startup and INDRAS research proposes drug for Covid-19 treatment
CEO, ReaGene Innovations, Dr. Uday Saxena
whatsapp facebook twitter telegram

Hyderabad: Research by ReaGene Innovations Private Limited, a startup incubated at the ASPIRE-BioNEST, and INDRAS Private Limited suggests that an anti-diabetic drug Ertugliflozin, can be repurposed to treat Covid-19.

According to the findings, the repurposed drug binds effectively to the receptor binding domain of the spike protein of Covid-19 and also displayed significant anti-inflammatory and antithrombotic properties in a 3D human lung model.

The first result offering a safe, ready-to-use and cost-effective solution for Covid-19 treatment, Ertugliflozin is an FDA approved drug for type-2 diabetes and acts against diabetes by removing excessive glucose through urine. “It has immense potential to treat Covid-19 infection and our research proved its efficacy in test-tube assays,” said Dr. Uday Saxena, CEO, ReaGene Innovations.

This research, funded by IT giant Tech Mahindra, was done by a team led by Dr. Ratnakar Palakodeti, Global Practice Head of Life Sciences and Nikhil Malhotra, Global Head, Makers Lab in the scientific partnership of INDRAS and ReaGene. The outcome of the research was recently published in a journal and a patent was also filed for the same. “We have found a molecule that can potentially attack corona virus. We have applied for a joint patent,” said Malhotra.

ASPIRE-BioNEST is a life sciences incubator jointly funded by BIRAC, a not-for-profit organisation of Department of Biotechnology, Government of India and University of Hyderabad, and incubates startups like ReaGene, helping them achieve their goals by providing plug-and-play facilities.


Now you can get handpicked stories from Telangana Today on Telegram everyday. Click the link to subscribe.
Click to follow Telangana Today Facebook page and Twitter .


Telangana Today Whatsapp
  • Follow Us :
  • Tags
  • anti-diabetic drug
  • ASPIRE-BioNEST
  • Covid-19
  • COVID-19 drug

Related News

  • Wife’s efforts to meet expenses no ground to reduce maintenance amount by husband: Delhi HC

    Wife’s efforts to meet expenses no ground to reduce maintenance amount by husband: Delhi HC

  • University of Hyderabad professor selected for JC Bose National Fellowship

    University of Hyderabad professor selected for JC Bose National Fellowship

  • China propels Apple’s growth in last 9 years, net sales up by 128%: Report

    China propels Apple’s growth in last 9 years, net sales up by 128%: Report

  • Memorial for journalists killed during COVID-19 to be inaugurated on October 2

    Memorial for journalists killed during COVID-19 to be inaugurated on October 2

  • India records 40 fresh Covid-19 cases on Monday

    India records 40 fresh Covid-19 cases on Monday

  • India reports 70 new Covid-19 cases

    India reports 70 new Covid-19 cases

Latest News

  • Govt hikes interest rate to 6.7 pc on five-year recurring deposit, retains rate on other small savings schemes

    18 seconds ago
  • Meesho to begin festive season sale from October 6

    3 mins ago
  • Massive fire breaks out in Delhi’s Azadpur Market, no casualties reported

    4 mins ago
  • NRI family of four buried a month of death following DNA identification

    6 mins ago
  • Late Irrigation Advisor’s vision for his village realized through Government initiatives

    5 mins ago
  • Centre requested to enhance subsistence allowance for fishermen during fishing ban period

    15 mins ago
  • Lightning claims two lives in Telangana

    18 mins ago
  • Kurukshetra battle shortly in AP: Jagan

    19 mins ago

company

  • Home
  • About Us
  • Contact Us

business

  • Subscribe

telangana today

  • Telangana
  • Hyderabad
  • Latest News
  • Entertainment
  • World
  • Andhra Pradesh
  • Science & Tech
  • Sport

follow us

© Copyrights 2022 TELANGANA PUBLICATIONS PVT. LTD. All rights reserved. Powered by Veegam